BioLineRx Ltd.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -45.2% | -45.2% | -40.7% |
| FY2017 | -46.1% | -46.1% | -39.9% |
| FY2018 | -55.6% | -55.6% | -40.8% |
| FY2019 | -76.2% | -76.2% | -47.5% |
| FY2020 | -136.3% | -136.3% | -63.5% |
| FY2021 | -39.7% | -39.7% | -33.2% |
| FY2022 | -49.1% | -49.1% | -32.7% |
| FY2023 | -458.4% | -458.4% | -94.8% |
| FY2024 | -68.5% | -68.5% | -23.7% |
| FY2025 | -11.1% | -11.1% | -5.0% |